Development of gut microbiota along with its metabolites of preschool children

Jingjing Xiong1, Hongwei Hu1, Chuanzhi Xu2

  • 1Department of Pediatrics, the First Affiliated Hospital of Kunming Medical University, No. 295, Xichang Road, Xishan District, Kunming, 650032, China.

BMC Pediatrics
|January 7, 2022
PubMed

Insights

The gut microbiome and its metabolites, including bile acids and short-chain fatty acids, mature significantly by six months in infants. This indicates a critical window for intestinal microflora development in children.

Area of Science:

  • Microbiology
  • Pediatrics
  • Gastroenterology

Background:

  • Investigating the dynamic changes in intestinal microbial communities and their metabolic functions during early childhood.
  • Understanding the development of gut microbiota and its associated metabolites like bile acids and short-chain fatty acids in healthy children.

Purpose of the Study:

  • To characterize the alterations in intestinal microbial abundance and composition in healthy children from infancy to preschool age.
  • To analyze the changes in fecal bile acid and short-chain fatty acid levels corresponding to gut microbiota development.

Main Methods:

  • Fecal samples collected from 120 newborns and 150 children (6 months to 6 years).
  • Intestinal flora composition analyzed using 16S rRNA gene sequencing.
  • Bile acids and short-chain fatty acids quantified via LC-MS and GC methods.

Main Results:

  • Intestinal microflora composition and function were unstable in newborns, improving by 6 months.
  • Microbiota stabilized and approached adult-like patterns after 2-3 years of age.
  • Levels of short-chain fatty acids and secondary bile acids correlated with gut microbiota maturation.

Conclusions:

  • The age of 6 months represents a potentially critical period for intestinal microflora development in children.
  • Early life gut microbiome development follows a distinct trajectory, influenced by microbial and metabolic changes.
Abstract

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
83.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
720
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12